These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 22537434

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.
    Alvarez-Lajonchere L, Dueñas-Carrera S.
    Int Rev Immunol; 2012 Jun; 31(3):223-42. PubMed ID: 22587022
    [Abstract] [Full Text] [Related]

  • 23. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT.
    Top HIV Med; 2005 Jun; 13(4):112-6. PubMed ID: 16304454
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M.
    Cancer; 1997 Dec 01; 80(11):2060-7. PubMed ID: 9392327
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis C virus infection in mouse hepatoma cells co-expressing human CD81 and Sip-L.
    Yeh CT, Lai HY, Yeh YJ, Cheng JC.
    Biochem Biophys Res Commun; 2008 Jul 18; 372(1):157-61. PubMed ID: 18474223
    [Abstract] [Full Text] [Related]

  • 27. Natural history of hepatitis C and the impact of anti-viral therapy.
    Boyer N, Marcellin P.
    Forum (Genova); 2000 Jul 18; 10(1):4-18. PubMed ID: 10717254
    [Abstract] [Full Text] [Related]

  • 28. Hepatitis C virus genetic variability in patients undergoing antiviral therapy.
    Cristina J, del Pilar Moreno M, Moratorio G.
    Virus Res; 2007 Aug 18; 127(2):185-94. PubMed ID: 17449128
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation systems for anti-HCV drugs.
    Moriishi K, Matsuura Y.
    Adv Drug Deliv Rev; 2007 Oct 10; 59(12):1213-21. PubMed ID: 17720275
    [Abstract] [Full Text] [Related]

  • 34. Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus.
    Roe B, Hall WW.
    Expert Rev Mol Med; 2008 Oct 20; 10():e30. PubMed ID: 18928579
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Acute hepatitis C virus infection.
    Chung RT.
    Clin Infect Dis; 2005 Jul 01; 41 Suppl 1():S14-7. PubMed ID: 16265608
    [Abstract] [Full Text] [Related]

  • 38. NK cells prevalence, subsets and function in viral hepatitis C.
    Zeromski J, Mozer-Lisewska I, Kaczmarek M, Kowala-Piaskowska A, Sikora J.
    Arch Immunol Ther Exp (Warsz); 2011 Dec 01; 59(6):449-55. PubMed ID: 21972016
    [Abstract] [Full Text] [Related]

  • 39. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep 01; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.